samedan logo
 
 
spacer
home > ebr > summer 2004 > a discussion of the ethical issues which surround pharmacogenetics
PUBLICATIONS
European BioPharmaceutical Review

A Discussion of the Ethical Issues which Surround Pharmacogenetics

People often respond differently to the same medicine. Few medicines are effective for everyone and all may cause adverse reactions or even, occasionally, death. Pharmacogenetics, the study of genetic variation between individuals that affects response to medicines, has the potential to play an important role in improving safety and efficacy. Not only do adverse reactions to medicines have significant costs, in both human and monetary terms, but considerable resources are wasted on prescribing medicines that have little or no effect for particular patients.

Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Sandy Thomas, Director of the Nuffield Council on Bioethics

Dr Sandy Thomas is Director of the Nuffield Council on Bioethics and Senior Fellow, Science Policy and Technology Research Unit (SPRU) at the University of Sussex. She trained as a Scientist at the University of London (BSc Botany and Zoology, MSc Crop Protection, PhD (Plant Genetics). After lecturing in genetics at the University of London, she became Research Fellow at the Science Policy Research and Technology Unit at the University of Sussex (1987-1997) where she specialised in policy research in life sciences and biotechnology. In 1997, she was appointed as Director of the Nuffield Council on Bioethics through a secondment from the University of Sussex. Over the past decade, she has published widely on the development of public policy for biotechnology, particularly in the area of intellectual property rights and the development and application of genomics. She was a member of the recent UK DFID Commission on Intellectual Property Rights.

spacer
Dr Sandy Thomas
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

FT Global Pharmaceutical and Biotechnology Conference 2008

2-3 December 2008, The Cumberland, London

FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >>

 
News and Press Releases

BASi Opens New Office in Europe

12th November 2008
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement